Louis Frederic Diehl | Scholars@Duke

Louis Frederic Diehl
Professor of Medicine

Research interests include Hodgkin disease, non-Hodgkin lymphomas, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia.

Current Appointments & Affiliations

Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2017
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2013

Contact Information

5170 Hosp South, Durham, NC 27710
Duke Box 3872, Durham, NC 27710
louis.diehl@duke.edu (919) 681-7648

Background
Education, Training, & Certifications
- Fellow in Hematology-Oncology, Medicine, Walter Reed Army Medical Center 1978 - 1981
- Medical Resident, Medicine, Walter Reed Army Medical Center 1975 - 1978
- M.D., Georgetown University 1975
Duke Appointment History
- Professor of Medicine, Medicine, Hematological Malignancies, Medicine 2012 - 2017
- Professor of Medicine, Medicine, Medical Oncology, Medicine 2006 - 2012
- Clinical Professor of Medicine, Medicine, Medical Oncology, Medicine 2005 - 2006
- Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 2004 - 2005
Recognition
In the News
- SEP 13, 2013 CBS News, AP
  
  FDA panel supports Perjeta for early-stage breast cancer
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Hudson, KE, Rizzieri, D, Thomas, SM, LeBlanc, TW, Powell, Z, Diehl, L, Moore, JO, DeCastro, C, and Beaven, AW. "Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study." British Journal of Haematology 184, no. 4 (February 2019): 647-650. (Letter) Full Text
  - Heyman, B, Rizzieri, D, Adams, DJ, De Castro, C, Diehl, L, Li, Z, Moore, J, and Beaven, A. "Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma." Clinical Lymphoma, Myeloma & Leukemia 18, no. 10 (October 2018): 679-686. Full Text
  - Mylam, KJ, Kostakoglu, L, Hutchings, M, Coleman, M, Lamonica, D, Czuczman, MS, Diehl, LF, Nielsen, AL, Jensen, P, Loft, A, Hendel, HW, Iyer, V, Leppä, S, Jyrkkiö, S, Holte, H, Eriksson, M, Gillstrøm, D, Hansen, PB, Seppänen, M, Hjorthaug, K, Brown, PDN, and Pedersen, LM. "(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study." Leukemia & lymphoma 56, no. 7 (July 2015): 2005-2012. Full Text
  - Torok, JA, Wu, Y, Prosnitz, LR, Kim, GJ, Beaven, AW, Diehl, LF, and Kelsey, CR. "Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma." International Journal of Radiation Oncology, Biology, Physics 92, no. 1 (May 2015): 54-59. Full Text
  - Beaven, AW, and Diehl, LF. "Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma." Hematology. American Society of Hematology. Education Program 2015 (January 2015): 550-558. Full Text
  - Boyle, J, Beaven, AW, Diehl, LF, Prosnitz, LR, and Kelsey, CR. "Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy." Oncology (Williston Park, N.Y.) 28, no. 12 (December 2014): 1074-1084.
  - Hutchings, M, Kostakoglu, L, Zaucha, JM, Malkowski, B, Biggi, A, Danielewicz, I, Loft, A, Specht, L, Lamonica, D, Czuczman, MS, Nanni, C, Zinzani, PL, Diehl, L, Stern, R, and Coleman, M. "In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 32, no. 25 (September 2014): 2705-2711. Full Text
  - Brander, D, Rizzieri, D, Gockerman, J, Diehl, L, Shea, TC, Decastro, C, Moore, JO, and Beaven, A. "Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma." Leukemia & lymphoma 54, no. 12 (December 2013): 2627-2630. Full Text
  - Held, LA, Rizzieri, D, Long, GD, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Horwitz, ME, Chao, NJ, and Gasparetto, C. "A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma." Cancer Investigation 31, no. 3 (March 2013): 172-176. Full Text
  - DiLillo, DJ, Weinberg, JB, Yoshizaki, A, Horikawa, M, Bryant, JM, Iwata, Y, Matsushita, T, Matta, KM, Chen, Y, Venturi, GM, Russo, G, Gockerman, JP, Moore, JO, Diehl, LF, Volkheimer, AD, Friedman, DR, Lanasa, MC, Hall, RP, and Tedder, TF. "Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function." Leukemia 27, no. 1 (January 2013): 170-182. Full Text Link to Item
  - Dilillo, DJ, Weinberg, JB, Yoshizaki, A, Horikawa, M, Bryant, JM, Iwata, Y, Matsushita, T, Matta, KM, Chen, Y, Venturi, GM, Russo, G, Gockerman, JP, Moore, JO, Diehl, LF, Volkheimer, AD, Friedman, DR, Lanasa, MC, Hall, RP, and Tedder, TF. "Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function." Leukemia 27, no. 1 (2013): 170-182. Full Text
  - Morris, TA, DeCastro, CM, Diehl, LF, Gockerman, JP, Lagoo, AS, Li, Z, Moore, JO, Rizzieri, DA, and Rao, AV. "Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia." Leuk Res 37, no. 1 (January 2013): 28-31. Full Text Link to Item
  - Kelsey, CR, Beaven, AW, Diehl, LF, and Prosnitz, LR. "Combined-modality therapy for early-stage Hodgkin lymphoma: maintaining high cure rates while minimizing risks." Oncology (Williston Park, N.Y.) 26, no. 12 (December 2012): 1182-1193. (Review)
  - Dorth, JA, Prosnitz, LR, Broadwater, G, Diehl, LF, Beaven, AW, Coleman, RE, and Kelsey, CR. "Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging." International Journal of Radiation Oncology, Biology, Physics 84, no. 3 (November 2012): 762-767. Full Text
  - Rao, AV, Rizzieri, DA, DeCastro, CM, Diehl, LF, Lagoo, AS, Moore, JO, and Gockerman, JP. "Phase I study of dose dense induction and consolidation with gemtuzumab ozogamicin and high dose cytarabine in older adults with AML." Journal of Geriatric Oncology 3, no. 3 (July 1, 2012): 220-227. Full Text
  - Lanasa, MC, Davis, PH, Datto, M, Li, Z, Gockerman, JP, Moore, JO, DeCastro, CM, Friedman, DR, Diehl, LF, Rehder, C, Cook, H, Daugherty, FJ, Matta, KMB, Weinberg, JB, and Rizzieri, D. "Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia." Leukemia & Lymphoma 53, no. 2 (February 2012): 218-224. Full Text
  - Kelsey, CR, Beaven, AW, Diehl, LF, and Prosnitz, LR. "Combined-modality therapy for early-stage Hodgkin lymphoma: Maintaining high cure rates while minimizing risks." Oncology (United States) 26, no. 12 (January 1, 2012). (Review)
  - Christensen, DJ, Chen, Y, Oddo, J, Matta, KM, Neil, J, Davis, ED, Volkheimer, AD, Lanasa, MC, Friedman, DR, Goodman, BK, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Vitek, MP, and Weinberg, JB. "SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target." Blood 118, no. 15 (October 13, 2011): 4150-4158. Full Text Link to Item
  - Dorth, JA, Chino, JP, Prosnitz, LR, Diehl, LF, Beaven, AW, Coleman, RE, and Kelsey, CR. "The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans." Annals of Oncology : Official Journal of the European Society for Medical Oncology 22, no. 2 (February 2011): 405-410. Full Text
  - Advani, AS, Shadman, M, Ali-Osman, F, Barker, A, Rybicki, L, Kalaycio, M, Sekeres, MA, de Castro, CM, Diehl, LF, Moore, JO, Beaven, A, Copelan, E, Sobecks, R, Talea, P, and Rizzieri, DA. "A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse." Clinical Lymphoma, Myeloma & Leukemia 10, no. 6 (December 2010): 473-476. Full Text
  - Kelsey, CR, Beaven, AW, Diehl, LF, and Prosnitz, LR. "Radiation therapy in the management of diffuse large B-cell lymphoma: still relevant?." Oncology (Williston Park) 24, no. 13 (November 30, 2010): 1204-1212. Link to Item
  - Mowery, YM, Weinberg, JB, Kennedy, MN, Bond, KM, Moore, JO, Lanasa, MC, Gockerman, JP, Diehl, LF, Pizzo, SV, Cianciolo, GJ, and Friedman, DR. "LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells." Leukemia 24, no. 9 (September 2010): 1580-1587. Full Text Link to Item
  - Crout, CA, Koh, L-P, Gockerman, JP, Moore, JO, Decastro, C, Long, GD, Diehl, L, Gasparetto, C, Niedzwiecki, D, Edwards, J, Prosnitz, L, Horwitz, M, Chute, J, Morris, A, Davis, P, Beaven, A, Chao, NJ, Ali-Osman, F, and Rizzieri, DA. "Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy." Cancer Invest 28, no. 6 (July 2010): 654-660. Full Text Link to Item
  - Friedman, DR, Magura, LA, Warren, HAC, Harrison, JD, Diehl, LF, and Weinberg, JB. "Statin use and need for therapy in chronic lymphocytic leukemia." Leukemia and Lymphoma 51, no. 12 (2010): 2295-2298. Full Text
  - Gasparetto, C, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Long, GD, Horwitz, ME, Keogh, G, Chute, JP, Sullivan, KM, Neuwirth, R, Davis, PH, Sutton, LM, Anderson, RD, Chao, NJ, and Rizzieri, D. ""Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma." Biol Blood Marrow Transplant 16, no. 1 (January 2010): 70-77. Full Text Link to Item
  - Kelsey, CR, Beaven, AW, Diehl, LF, and Prosnitz, LR. "Radiation therapy in the management of diffuse large B-cell lymphoma: still relevant?." Oncology (Williston Park, N.Y.) 24, no. 13 (2010): 1204-1212.
  - Friedman, DR, Weinberg, JB, Barry, WT, Goodman, BK, Volkheimer, AD, Bond, KM, Chen, Y, Jiang, N, Moore, JO, Gockerman, JP, Diehl, LF, Decastro, CM, Potti, A, and Nevins, JR. "A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia." Clin Cancer Res 15, no. 22 (November 15, 2009): 6947-6955. Full Text Link to Item
  - Shah, A, Diehl, LF, and St Clair, EW. "T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia." Clin Immunol 132, no. 2 (August 2009): 145-152. Full Text Link to Item
  - Rizzieri, DA, O'Brien, JA, Broadwater, G, Decastro, CM, Dev, P, Diehl, L, Beaven, A, Lagoo, A, Gockerman, JP, Chao, NJ, and Moore, JO. "Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia." Cancer 115, no. 13 (July 2009): 2922-2929. Full Text
  - de Castro, C, Adams, D, Rizzieri, D, Moore, J, Gockerman, J, Diehl, L, Horwitz, M, Edmonds, E, and Warzecho, J. "P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes." Leukemia Research 33, no. SUPPL. 1 (May 1, 2009). Full Text
  - de Castro, C, Adams, D, Rizzieri, D, Moore, J, Gockerman, J, Diehl, L, Horwitz, M, Edmonds, E, and Warzecho, J. "P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes." Leukemia Research 33, no. SUPPL. 1 (May 1, 2009). Full Text
  - Weinberg, JB, Volkheimer, AD, Mihovilovic, M, Jiang, N, Chen, Y, Bond, K, Moore, JO, Gockerman, JP, Diehl, LF, de Castro, CM, Rizzieri, DA, Levesque, MC, Dekroon, R, and Strittmatter, WJ. "Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia." Leukemia 22, no. 12 (December 2008): 2184-2192. Full Text Link to Item
  - Christensen, DJ, Bond, KM, Volkheimer, AD, Oddo, J, Chen, Y, Gockerrnan, JP, Moore, JO, Diehl, LF, de Castro, CM, Vitek, MP, and Weinberg, B. "Apolipoprotein E-Mimetic Therapeutic Peptides Mediate CLL Cell Cytotoxicity." BLOOD 112, no. 11 (November 16, 2008): 140-140. Link to Item
  - Gasparet, C, Gockerman, JP, Diehl, LF, III, DCC, Moore, J, Long, GD, Horwitz, M, Chute, J, Sullivan, KM, Netuwirth, R, Davis, PH, Sutton, LM, Anderson, RD, Chao, N, and Rizzieri, DA. "Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma." BLOOD 112, no. 11 (November 16, 2008): 1142-1142. Link to Item
  - Weinberg, JB, Volkheimer, AD, Chen, Y, Beasley, BE, Jiang, N, Lanasa, MC, Friedman, D, Vaccaro, G, Rehder, CW, Decastro, CM, Rizzieri, DA, Diehl, LF, Gockerman, JP, Moore, JO, Goodman, BK, and Levesque, MC. "Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia." American Journal of Hematology 82, no. 12 (December 2007): 1063-1070. Full Text
  - Berdeja, JG, Hess, A, Lucas, DM, O'Donnell, P, Ambinder, RF, Diehl, LF, Carter-Brookins, D, Newton, S, and Flinn, IW. "Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab." Clinical Cancer Research 13, no. 8 (2007): 2392-2399. Full Text
  - Waselenko, JK, Reese, A, Park, K, Lucas, M, Goodrich, A, Willis, CR, Diehl, LF, Grever, MR, Byrd, JC, and Flinn, IW. "A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma." Annals of Hematology 85, no. 5 (2006): 301-307. Full Text
  - Matsui, W, Smith, BD, Vala, M, Beal, N, Huff, CA, Diehl, LF, and Jones, RJ. "Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia." British Journal of Haematology 128, no. 6 (March 2005): 853-862. Full Text
  - Kasamon, YL, Flinn, IW, Grever, MR, Diehl, LF, Garrett-Mayer, E, Goodman, SN, Lucas, MS, and Byrd, JC. "Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia." Clinical Cancer Research 11, no. 23 (2005): 8413-8417. Full Text
  - Kasamon, YL, Jones, RJ, Diehl, LF, Nayer, H, Borowitz, MJ, Garrett-Mayer, E, Ambinder, RF, Abrams, RA, Zhang, Z, and Flinn, IW. "Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma." Biology of Blood and Marrow Transplantation 11, no. 1 (2005): 39-46. Full Text
  - Huff, CA, Fuchs, EJ, Noga, SJ, O'Donnell, PV, Ambinder, RF, Diehl, L, Borrello, I, Vogelsang, GB, Miller, CB, Flinn, IA, Brodsky, RA, Marcellus, D, and Jones, RJ. "Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: Importance of allogeneic T cells." Biology of Blood and Marrow Transplantation 9, no. 5 (2003): 312-319. Full Text
  - Willard, RJ, Turiansky, GW, Genest, GP, Davis, BJ, and Diehl, LF. "Leukemia cutis in a patient with chronic neutrophilic leukemia." Journal of the American Academy of Dermatology 44, no. 2 SUPPL. (2001): 365-369. Full Text
  - Flinn, IW, Byrd, JC, Morrison, C, Jamison, J, Diehl, LF, Murphy, T, Piantadosi, S, Seifter, E, Ambinder, RF, Vogelsang, G, and Grever, MR. "Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies." Blood 96, no. 1 (2000): 71-75.
  - Flinn, IW, Goodman, SN, Post, L, Jamison, J, Miller, CB, Gore, S, Diehl, L, Willis, C, Ambinder, RF, and Byrd, JC. "A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL." Annals of Oncology 11, no. 6 (2000): 691-695. Full Text
  - LeBrun, CJ, Diehl, LF, Abbott, KC, Welch, PG, and Yuan, CM. "Life expectancy benefits of cancer screening in the end-stage renal disease population." American Journal of Kidney Diseases 35, no. 2 (2000): 237-243.
  - Diehl, LF, Karnell, LH, and Menck, HR. "The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia." Cancer 86, no. 12 (December 1999): 2684-2692. Full Text
  - Byrd, JC, McGrail, LH, Hospenthal, DR, Howard, RS, Dow, NA, and Diehl, LF. "Herpes virus infections occur frequently following treatment with fludarabine: Results of a prospective natural history study." British Journal of Haematology 105, no. 2 (1999): 445-447.
  - Shorr, AF, Trotta, RF, Alkins, SA, Hanzel, GS, and Diehl, LF. "D-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease." Intensive Care Medicine 25, no. 2 (1999): 207-210. Full Text
  - Kornblith, AB, Herndon, JE, Zuckerman, E, Cella, DF, Cherin, E, Wolchok, S, Weiss, RB, Diehl, LF, Henderson, E, Cooper, MR, Schiffer, C, Canellos, GP, Mayer, RJ, Silver, RT, Schilling, A, Peterson, BA, Greenberg, D, and Holland, JC. "Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B." Annals of Oncology : Official Journal of the European Society for Medical Oncology 9, no. 3 (March 1998): 297-306. Full Text
  - Byrd, JC, Shinn, C, Waselenko, JK, Fuchs, EJ, Lehman, TA, Nguyen, PL, Flinn, IW, Diehl, LF, Sausville, E, and Grever, MR. "Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53." Blood 92, no. 10 (1998): 3804-3816.
  - Diehl, LF, and Ketchum, LH. "Autoimmune disease and chronic lymphocytic leukemia: Autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia." Seminars in Oncology 25, no. 1 (1998): 80-97.
  - Weiss, RB, Freiman, J, Kweder, SL, Diehl, LF, and Byrd, JC. "Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia." Journal of Clinical Oncology 16, no. 5 (1998): 1885-1889.
  - Wiesen, AR, Byrd, JC, Hospenthal, DR, Howard, RS, Shorr, AR, Glass, KL, and Diehl, LF. "Transient abnormalities in serum bilirubin and lactate dehydrogenase levels following red blood cell transfusions in adults." American Journal of Medicine 104, no. 2 (1998): 144-147. Full Text
  - Ringel, MD, Taylor, T, Barsouk, A, Wall, JR, Freter, CE, Howard, RS, Diehl, L, and Burman, KD. "Hodgkin's disease treated with neck radiation is associated with increased antibody-dependent cellular cytotoxicity against human extraocular muscle cells." Thyroid 7, no. 3 (1997): 425-432.
  - Shields, DJ, Byrd, JC, Abbondanzo, SL, Lichy, JH, Diehl, LF, and Aguilera, NI. "Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment." Modern Pathology 10, no. 11 (1997): 1151-1159.
  - Diehl, LF, Bolan, CD, and Weiss, RB. "Hemolytic anemia and cancer." Cancer Treatment Reviews 22, no. 1 (1996): 33-73. Full Text
  - Jr, DAS, Phillips, ET, Weiss, RB, Dawson, NA, Diehl, LF, and Rickles, NM. "Hypertensive reactions associated with paclitaxel." Cancer Investigation 14, no. 4 (1996): 340-342.
  - Byrd, JC, Hargis, JB, Kester, KE, Hospenthal, DR, Knutson, SW, and Diehl, LF. "Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis." American journal of hematology 49, no. 2 (June 1995): 135-142. Full Text
  - Byrd, JC, Hertler, AA, Weiss, RB, Freiman, J, Kweder, SL, and Diehl, LF. "Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia." Annals of Oncology 6, no. 3 (1995): 300-301.
  - Wiesen, AR, Hospenthal, DR, Byrd, JC, Glass, KL, Howard, RS, and Diehl, LF. "Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleeding." Annals of Internal Medicine 121, no. 4 (1994): 278-280.
  - Vukelja, SJ, Krishnan, J, and Diehl, LF. "Mean platelet volume improves upon the megathrombocyte index but cannot replace the blood film examination in the evaluation of thrombocytopenia." American Journal of Hematology 44, no. 2 (1993): 89-94.
  - Diehl, LF. "Congenital Neutropenia: How Low?-Reply." Archives of Internal Medicine 152, no. 6 (June 1, 1992): 1329-1329. Full Text
  - Tomases, A, Reed, WW, Diehl, LF, and Bessman, D. "Congenital neutropenia: How low? [1]." Archives of Internal Medicine 152, no. 6 (1992): 1329--.
  - Reed, WW, and Diehl, LF. "Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks." Archives of internal medicine 151, no. 3 (March 1991): 501-505. Full Text
  - Reed, WW. "Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks." Archives of Internal Medicine 151, no. 3 (March 1, 1991): 501-505. Full Text
  - Diehl, LF, Hopper, KD, Giguere, J, Granger, E, and Lesar, M. "The pattern of intrathoracic hodgkin's disease assessed by computed tomography." Journal of Clinical Oncology 9, no. 3 (1991): 438-443.
  - Diehl, LF. "Radiation and chemotherapy in the treatment of esophageal cancer." Gastroenterology Clinics of North America 20, no. 4 (1991): 765-774.
  - Hopper, KD, Diehl, LF, Lynch, JC, and McCauslin, MA. "Mediastinal bulk in Hodgkin disease: Method of measurement versus prognosis." Investigative Radiology 26, no. 12 (1991): 1101-1110.
  - Hargis, JB, Waddell, DJ, Diehl, L, and Redmond, J. "Induction chemotherapy in Jehovah's Witnesses with leukaemia." Lancet 336, no. 8714 (1990): 563-564.
  - Hopper, KD, Diehl, LF, Cole, BA, Lynch, JC, Meilstrup, JW, and McCauslin, MA. "The significance of necrotic mediastinal lymph nodes on CT in patients with newly diagnosed Hodgkin disease." American Journal of Roentgenology 155, no. 2 (1990): 267-270.
  - Vukelja, SJ, Andejeski, Y, Giguere, JK, Yuen, A, and Diehl, LF. "Enlargement of mediastinal masses on simulation films: A radiotherapeutic problem in the management of patients with Hodgkin's disease." Medical and Pediatric Oncology 18, no. 1 (1990): 44-48. Full Text
  - Ellis, ME, Diehl, LF, Granger, E, and Elson, E. "Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: Sensitivity and specificity of the Ann Arbor staging procedure criteria." American Journal of Hematology 30, no. 3 (1989): 115-120.
  - Hopper, KD, and Diehl, LF. "RE: Hodgkin disease Clinical utility of CT in initial staging and treatment." Investigative Radiology 24, no. 10 (January 1, 1989): 823-. (Letter)
  - Simmons, JO, Noel, GL, and Diehl, LF. "Does review of peripheral blood smears help in the initial workup of common anemias?." Journal of General Internal Medicine 4, no. 6 (1989): 473-481. Full Text
  - Diehl, LF, Banks, A, Carter, W, Klein, MA, Muss, HB, and Weiss, RB. "Fatal esorubicin-induced cardiomyopathy: report of a case and review of the literature." Cancer Chemotherapy and Pharmacology 21, no. 4 (1988): 347-350. Full Text
  - Glass, AR, Reed, W, and Diehl, L. "Hematologic indexes in men attending an infertility clinic." Archives of andrology 20, no. 2 (January 1988): 177-180. Full Text
  - Glass, AR, Reed, W, and Diehl, L. "Hematologic indexes in men attending an infertility clinic." Archives of Andrology 20, no. 2 (1988): 177-180.
  - Hopper, KD, Diehl, LF, Lesar, M, Barnes, M, Granger, E, and Baumann, J. "Hodgkin disease: Clinical utility of CT in initial staging and treatment." Radiology 169, no. 1 (1988): 17-22.
  - Diehl, LF, and Perry, DJ. "A comparison of randomized concurrent control groups with matched historical control groups: Are historical controls valid?." Journal of Clinical Oncology 4, no. 7 (1986): 1114-1120.
  - Perry, DJ, and Diehl, LF. "Changes in criteria for tumor response." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 3, no. 2 (February 1985): 287-null. (Letter) Full Text
  - Adams, JD, Diehl, LF, and Wilson, JP. "Ambulatory use of high-dose intravenous morphine for severe pain." Drug Intelligence and Clinical Pharmacy 18, no. 2 (1984): 138-140.
  - Diehl, LF, Hurwitz, MA, Johnson, SA, Butler, WM, and Taylor, HG. "Skin metastases confined to a field of previous irradiation. Report of two cases and review of the literature." Cancer 53, no. 9 (1984): 1864-1868.
  - Diehl, LF, Perry, DJ, and Tang, DB. "Study on the comparability of 6 versus 12 cycles of adjuvant cyclophosphamide, methotrexate, and fluorouracil." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 1, no. 10 (October 1983): 663-664. (Letter) Full Text
  - Diehl, LF, Perry, DJ, Terebelo, H, Baldwin, PE, Hurwitz, M, Kimball, DB, and Dorn, RV. "Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy." Cancer Treatment Reports 67, no. 9 (1983): 827-829.
  - Butler, WM, Diehl, LF, Taylor, HG, and Weltz, MD. "Metastatic thymoma with myasthenia gravis. Complete remission with combination chemotherapy." Cancer 50, no. 3 (1982): 419-422.
  - Diehl, L, Perry, D, and Terebelo, H. "Radiation as salvage therapy for patients with Hodgkin's disease (HD) relapsing after MOPP chemotherapy." Proceedings of the American Society of Clinical Oncology Vol. 1 (1982): C-612.
  - Hooks, JJ, Haynes, BF, Detrick-Hooks, B, Diehl, LF, Gerrard, TL, and Fauci, AS. "Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease." Blood 59, no. 1 (January 1982): 198-201.
  - Schoomaker, EB, Butler, WM, and Diehl, LF. "Increased heat sensitivity of red blood cells in hereditary elliptocytosis with acquired cobalamin (vitamin B₁₂) deficiency." Blood 59, no. 6 (1982): 1213-1219.
  - Butler, WM. "Lhermitte's sign in cobalamin (vitamin B12) deficiency." Jama: the Journal of the American Medical Association 245, no. 10 (March 13, 1981): 1059-1059. Full Text
  - Butler, WM, Taylor, HG, and Diehl, LF. "Lhermitte's sign in cobalamin (vitamin B12) deficiency." JAMA 245, no. 10 (March 1981): 1059-. Full Text
  - Hooks, JJ, Haynes, BF, Detrick-Hooks, B, Diehl, LF, Gerrard, TL, and Fauci, AS. "Gamma (immune) interferon produced by leukocytes from a patients with a T cell proliferation disease." Trans Assoc Am Physicians 94 (1981): 198-203. Link to Item
- Conference Papers
  - Sung, AD, de Castro, CM, LeBlanc, TW, Long, GD, Adams, DB, Brander, DM, Dave, S, Diehl, LF, Phuong, LD, Hennig, T, Kang, Y, McKinney, MS, Rein, LAM, Sipkins, DA, Yang, Y, Chao, NJ, and Rizzieri, DA. "Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia." 59th Annual Meeting of the American-Society-of-Hematology (ASH). Atlanta, GA. December 9, 2017 - December 12, 2017.: AMER SOC HEMATOLOGY, December 7, 2017. Link to Item
  - Sivaraj, D, Green, MM, Kang, Y, Rizzieri, D, Diehl, LF, Beaven, AW, Li, Z, Garrett, A, McIntyre, J, Long, GD, Chao, NJA, and Gasparetto, C. "Phase VII dose expansion of a trial investigating bendamustine and pomalidomide with dexamethasone (BPd) in patients with relapsed/refractory multiple myeloma." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL. June 2, 2017 - June 6, 2017.: AMER SOC CLINICAL ONCOLOGY, May 20, 2017. Full Text Link to Item
  - Gasparetto, C, Green, M, Srinivasan, A, Kang, Y, Rizzieri, DA, Decastro, C, Diehl, LF, Beaven, A, Li, Z, Rao, AV, Garrett, A, Tuchman, S, and Long, GD. "A Phase I-II Study of the Combination of Bendamustine and Pomalidomide with Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma." December 3, 2015. Link to Item
  - Ali, HA, Snyder, LD, Diehl, LF, Todd, JL, and Aryal, S. "Atypical Primary Effusion Lymphoma In A Lung Transplant Recipient." 2015. Link to Item
  - Brander, DM, Beaven, AW, Gockerman, JP, Diehl, LF, Gasparetto, C, Shea, TC, deCastro, C, Moore, JO, and Rizzieri, DA. "Phase II Study of VEGF Inhibitor, PTK787/ZK222584, in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma." November 16, 2012. Link to Item
  - Rao, A, Khan, G, Rizzieri, DA, Moore, JO, Gockerman, JP, Diehl, LF, Beaven, AW, Adams, D, Warzecho, J, and Decastro, C. "Phase 1 Study of Lenalidomide and Decitabine for High and Intermediate 2 Risk MDS." November 16, 2012. Link to Item
  - Rao, A, Rizzieri, DA, Vanegas, E, Moore, JO, Gockerman, JP, Diehl, LF, Adams, D, Warzecho, J, and Decastro, C. "Pilot Study of Sorafenib for Myelodysplastic Syndrome." November 16, 2012. Link to Item
  - Beaven, AW, Rizzieri, DA, Powell, Z, Li, Z, Alton, P, Warzecho, J, Diehl, LF, Moore, JO, III, DCCM, and Gockerman, JP. "High Complete Response Rates with Dose Dense/Dose Intense Chemotherapy Plus Radioimmunotherapy in High Risk Diffuse Large B Cell and Mantle Cell Lymphoma." November 18, 2011. Link to Item
  - Morris, TA, Rizzieri, DA, de Castro, CM, Diehl, LF, Gockerman, JP, Lagoo, AS, Moore, JO, and Rao, AV. "Re-Induction Therapy Decisions Based on Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia." November 18, 2011. Link to Item
  - Weinberg, JB, DiLillo, DJ, Iwata, Y, Matushita, T, Matta, KM, Venturi, GM, Russo, G, Chen, Y, Gockerman, JP, Moore, JO, Diehl, LF, Volkheimer, AD, Friedman, DR, Lanasa, MC, Hall, RP, and Tedder, TJ. "Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells." November 18, 2011. Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Selected Publications

Academic Articles

Conference Papers